Molecular pathologies and therapies for Pelizaeus-Merzbacher disease
Brain and Development · 2025
DOI: 10.1016/j.braindev.2025.104383 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain and Development, 2025. Verfasst von Ken Inoue. Beteiligte Einrichtung: Medical Genome Center, National Center of Neurology and Psychiatry (NCNP), Japan. Electronic address: kinoue@ncnp.go.jp. Hauptthemen laut MEDLINE: Pelizaeus-Merzbacher Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Genome Center, National Center of Neurology and Psychiatry (NCNP), Japan. Electronic address: kinoue@ncnp.go.jp.
Förderung
- Japan Agency for Medical Research and Development
- Ministry of Health, Labour and Welfare
Zitieren
APA
Inoue, K. (2025). Molecular pathologies and therapies for Pelizaeus-Merzbacher disease. Brain and Development. https://doi.org/10.1016/j.braindev.2025.104383
Vancouver
Inoue K. Molecular pathologies and therapies for Pelizaeus-Merzbacher disease. Brain and Development. 2025. doi:10.1016/j.braindev.2025.104383
BibTeX
@article{Inoue2025,
author = {Inoue, Ken},
title = {Molecular pathologies and therapies for Pelizaeus-Merzbacher disease},
journal = {Brain and Development},
year = {2025},
doi = {10.1016/j.braindev.2025.104383}
}
EUVIMED